Physiologic response to the inotropic and vasodilator properties of enoximone
- 1 August 1987
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (5), 15-20
- https://doi.org/10.1016/0002-9149(87)90519-4
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathyThe American Journal of Cardiology, 1986
- Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failureAmerican Heart Journal, 1985
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- End-systolic relations: their usefulness and limitations in assessing left ventricular contractile stateInternational Journal of Cardiology, 1984
- Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)Journal of Cardiovascular Pharmacology, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- The contractile behavior of the heart and its functional coupling to the circulationProgress in Cardiovascular Diseases, 1982
- Load Independence of the Instantaneous Pressure-Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the RatioCirculation Research, 1973
- Usefulness and limitations of the rate of rise of intraventricular pressure (dp/dt) in the evaluation of myocardial contractility in man∗The American Journal of Cardiology, 1969